Literature DB >> 21503662

[Follow-up of testicular germ cell cancer patients: interdisciplinary evidence-based recommendations].

M Hartmann1, S Krege, R Souchon, M De Santis, S Gillessen, R Cathomas.   

Abstract

BACKGROUND: Clear treatment recommendations for patients with testicular cancer exist and their stringent application has led to significant improvements in remission and survival rates. Moreover, active surveillance has become a cornerstone in the management of clinical stage I seminomatous and nonseminomatous germ cell tumors. On the other hand, the existing recommendations for the follow-up of testis cancer patients differ widely and have been changed frequently in recent years.
MATERIAL AND METHODS: Follow-up recommendations in this young patient population have to be as evidence-based as possible, feasible in order to ensure adherence, and should not be harmful. Primarily, attention has to be paid to the negative impact of unnecessary radiation exposure.
RESULTS: Recently, new evidence has become available regarding the relapse pattern of different disease stages of testicular cancer, the use of imaging at follow-up, and the risks of excessive radiation due to imaging, in particular that of CT scans. An interdisciplinary multinational working group consisting of urologists, medical oncologists, and radiation oncologists has reviewed and discussed the current evidence and on this basis formulated new recommendations for patients with germ cell tumors of the testis.

Entities:  

Mesh:

Year:  2011        PMID: 21503662     DOI: 10.1007/s00120-011-2556-0

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  32 in total

Review 1.  Computed tomography--an increasing source of radiation exposure.

Authors:  David J Brenner; Eric J Hall
Journal:  N Engl J Med       Date:  2007-11-29       Impact factor: 91.245

2.  Routine computerised tomographic scans of the thorax in surveillance of stage I testicular non-seminomatous germ-cell cancer--a necessary risk?

Authors:  M L Harvey; T R Geldart; R Duell; G M Mead; K Tung
Journal:  Ann Oncol       Date:  2002-02       Impact factor: 32.976

3.  Testis cancer survivors' health behaviors: comparison with age-matched relative and demographically matched population controls.

Authors:  Eileen H Shinn; Richard J Swartz; Bob B Thornton; Philippe E Spiess; Louis L Pisters; Karen M Basen-Engquist
Journal:  J Clin Oncol       Date:  2010-04-05       Impact factor: 44.544

4.  International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.

Authors: 
Journal:  J Clin Oncol       Date:  1997-02       Impact factor: 44.544

5.  The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.

Authors:  Janine Nuver; Andries J Smit; Bruce H R Wolffenbuttel; Wim J Sluiter; Harald J Hoekstra; Dirk T Sleijfer; Jourik A Gietema
Journal:  J Clin Oncol       Date:  2005-02-28       Impact factor: 44.544

6.  Is ultrasound of the retroperitoneum a valuable staging method in selecting testicular cancer patients for primary retroperitoneal lymph node dissection?

Authors:  Zaza Mezvrishvili; Zaza Tchanturaia; Tengiz Toidze; Nino Turmanidze; Maka Kekelidze; Laurent Managadze
Journal:  Urol Int       Date:  2007       Impact factor: 2.089

Review 7.  European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.

Authors:  Susanne Krege; Jörg Beyer; Rainer Souchon; Peter Albers; Walter Albrecht; Ferran Algaba; Michael Bamberg; István Bodrogi; Carsten Bokemeyer; Eva Cavallin-Ståhl; Johannes Classen; Christoph Clemm; Gabriella Cohn-Cedermark; Stéphane Culine; Gedske Daugaard; Pieter H M De Mulder; Maria De Santis; Maike de Wit; Ronald de Wit; Hans Günter Derigs; Klaus-Peter Dieckmann; Annette Dieing; Jean-Pierre Droz; Martin Fenner; Karim Fizazi; Aude Flechon; Sophie D Fosså; Xavier Garcia del Muro; Thomas Gauler; Lajos Geczi; Arthur Gerl; Jose Ramon Germa-Lluch; Silke Gillessen; Jörg T Hartmann; Michael Hartmann; Axel Heidenreich; Wolfgang Hoeltl; Alan Horwich; Robert Huddart; Michael Jewett; Johnathan Joffe; William G Jones; László Kisbenedek; Olbjørn Klepp; Sabine Kliesch; Kai Uwe Koehrmann; Christian Kollmannsberger; Markus Kuczyk; Pilar Laguna; Oscar Leiva Galvis; Volker Loy; Malcolm D Mason; Graham M Mead; Rolf Mueller; Craig Nichols; Nicola Nicolai; Tim Oliver; Dalibor Ondrus; Gosse O N Oosterhof; Luis Paz Ares; Giorgio Pizzocaro; Jörg Pont; Tobias Pottek; Tom Powles; Oliver Rick; Giovanni Rosti; Roberto Salvioni; Jutta Scheiderbauer; Hans-Ulrich Schmelz; Heinz Schmidberger; Hans-Joachim Schmoll; Mark Schrader; Felix Sedlmayer; Niels E Skakkebaek; Aslam Sohaib; Sergei Tjulandin; Padraig Warde; Stefan Weinknecht; Lothar Weissbach; Christian Wittekind; Eva Winter; Lori Wood; Hans von der Maase
Journal:  Eur Urol       Date:  2007-12-26       Impact factor: 20.096

Review 8.  Long-term sequelae after cancer therapy--survivorship after treatment for testicular cancer.

Authors:  Sophie D Fosså
Journal:  Acta Oncol       Date:  2004       Impact factor: 4.089

9.  Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197--the National Cancer Research Institute Testis Cancer Clinical Studies Group.

Authors:  Gordon J Rustin; Graham M Mead; Sally P Stenning; Paul A Vasey; Nina Aass; Robert A Huddart; Michael P Sokal; Jonathan K Joffe; Stephen J Harland; Sarah J Kirk
Journal:  J Clin Oncol       Date:  2007-04-10       Impact factor: 44.544

10.  Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse.

Authors:  N J van As; D C Gilbert; J Money-Kyrle; D Bloomfield; S Beesley; D P Dearnaley; A Horwich; R A Huddart
Journal:  Br J Cancer       Date:  2008-06-17       Impact factor: 7.640

View more
  5 in total

Review 1.  [Diagnosis, treatment and follow-up of testicular cancer].

Authors:  Susanne Krege
Journal:  Urologe A       Date:  2017-12       Impact factor: 0.639

2.  Can magnetic resonance imaging replace conventional computerized tomography for follow-up of patients with testicular cancer? A systematic review.

Authors:  Jonas Busch; Stefanie Schmidt; Peter Albers; Julia Heinzelbecker; Sabine Kliesch; Julia Lackner; David Pfister; Christian Ruf; Christian Winter; Friedemann Zengerling; Dirk Beyersdorff
Journal:  World J Urol       Date:  2022-01-17       Impact factor: 4.226

Review 3.  [Follow-up of testicular germ cell tumors-historical aspects and current recommendations].

Authors:  Klaus-Peter Dieckmann; Christian Guido Ruf; Raphael Gübitz; Christian Wülfing; Friedemann Zengerling
Journal:  Urologe A       Date:  2022-04-06       Impact factor: 0.639

4.  [Postchemotherapy residual tumour resection in complex metastatic sites of advanced testicular germ cell tumours].

Authors:  P Paffenholz; D Pfister; A Heidenreich
Journal:  Urologe A       Date:  2016-05       Impact factor: 0.639

5.  Testicular seminoma clinical stage 1: treatment outcome on a routine care level.

Authors:  Klaus-Peter Dieckmann; Inken Dralle-Filiz; Cord Matthies; Julia Heinzelbecker; Jens Bedke; Jörg Ellinger; Petra Anheuser; Rainer Souchon; Uwe Pichlmeier
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-26       Impact factor: 4.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.